AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H376-H384, 2007. First published March 16, 2007; doi:10.1152/ajpheart.01195.2006
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/H376    most recent
01195.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, M.-H.
Right arrow Articles by Uretsky, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, M.-H.
Right arrow Articles by Uretsky, B. F.

Mediating {delta}-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell

Ming-He Huang,1 Hui-Qun Wang,2 William R. Roeske,6 Yochai Birnbaum,1 Yewen Wu,1 Ning-Ping Yang,2 Yu Lin,1 Yumei Ye,1 David J. McAdoo,3 Michael G. Hughes,3 Scott D. Lick,4 Paul J. Boor,5 Charles Y. Lui,1 and Barry F. Uretsky1

1Department of Internal Medicine, Cardiology Division, 2Research Histopathology Core, 3Department of Neuroscience and Cell Biology, 4Department of Surgery, Division of Cardiothoracic Surgery, and 5Department of Pathology, University of Texas Medical Branch, Galveston, Texas; and 6Department of Medicine, University of Arizona, College of Medicine, Sarver Heart Center, Tucson, Arizona

Submitted 31 October 2006 ; accepted in final form 8 March 2007

Stimulation of cardiac beta2-adrenergic receptor (beta2-AR) or {delta}-opioid receptor (DOR) exerts a similar degree of cardioprotection against myocardial ischemia in experimental models. We hypothesized that {delta}-opioid-initiated cardioprotection is mediated by the intrinsic cardiac adrenergic (ICA) cell via enhanced epinephrine release. Using immunohistochemical and in situ hybridization methods, we detected in situ tyrosine hydroxylase (TH) mRNA and TH immunoreactivity that was colocalized with DOR immunoreactivity in ICA cells in human and rat hearts. Western blot analysis detected DOR protein in ICA cells isolated from rat ventricular myocytes. The physiology of DOR expression was examined by determining changes of cytosolic Ca2+ concentration ([Ca2+]i) transients in isolated rat ICA cells using fluorescence spectrophotometry. Exposing the selective {delta}-opioid agonist D-[Pen2,5]enkephalin (DPDPE) to ICA cells increased [Ca2+]i transients in a concentration-dependent manner. Such an effect was abolished by the Ca2+ channel blocker nifedipine. HPLC-electrochemical detection demonstrated a 2.4-fold increase in epinephrine release from ICA cells following DPDPE application. The significance of the ICA cell and its epinephrine release in {delta}-opioid-initiated cardioprotection was demonstrated in the rat myocardial infarction model and ICA cell-ventricular myocyte coculture. DPDPE administered before coronary artery occlusion or simulated ischemia-reperfusion reduced left ventricular infarct size by 54 ± 15% or myocyte death by 26 ± 4%, respectively. beta2-AR blockade markedly attenuated {delta}-opioid-initiated infarct size-limiting effect and abolished {delta}-opioid-initiated myocyte survival protection in rat ICA cell-myocyte coculture. Furthermore, {delta}-opioid agonist exerted no myocyte survival protection in the absence of cocultured ICA cells during ischemia-reperfusion. We conclude that {delta}-opioid-initiated myocardial infarct size reduction is primarily mediated via endogenous epinephrine/beta2-AR signaling pathway as a result of ICA cell activation.

{delta}-opioid receptor; epinephrine; myocardial ischemia



Address for reprint requests and other correspondence: M.-H. Huang, Univ. of Texas Medical Branch, Dept. of Internal Medicine, 5.106 John Sealy Annex, 301 University Blvd., Galveston, TX 77555-0553 (e-mail: mihuang{at}utmb.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Cholinergic location of {delta}-opioid receptors in canine atria and SA node
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H829 - H838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.